A detailed history of Fox Run Management, L.L.C. transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 22,678 shares of COGT stock, worth $177,795. This represents 0.06% of its overall portfolio holdings.

Number of Shares
22,678
Holding current value
$177,795
% of portfolio
0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$8.24 - $11.48 $186,866 - $260,343
22,678 New
22,678 $244,000
Q3 2023

Nov 07, 2023

BUY
$9.69 - $13.34 $97,975 - $134,880
10,111 New
10,111 $98,000
Q3 2022

Nov 07, 2022

BUY
$9.39 - $16.99 $174,851 - $316,370
18,621 New
18,621 $278,000

Others Institutions Holding COGT

About Cogent Biosciences, Inc.


  • Ticker COGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,758,300
  • Market Cap $516M
  • Description
  • Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...
More about COGT
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.